BioPharma Conference

Jim Mullen of Editas Medicine will tell ASAP BioPharma Conference attendees how to prevent intangible factors from derailing an alliance, including senior leadership turnover; asymmetries in knowledge, impact, size, or importance of the partner; or vague contract language, to name a few. Continue Reading

Novartis and Microsoft executives will demystify basic tech concepts, such as cloud-based solutions, tech stacks, and AI, as they explain what all biopharma alliance managers need to know about digital transformation—and why they need to understand it—at the ASAP BioPharma Conference Sept. 28–30. Continue Reading

Among the relatively new frontiers for biopharma partnering is the realm of digital therapeutics and digital health. A keynote speakers at the 2022 ASAP BioPharma Conference says new technologies and new approaches have the potential to democratize healthcare and revolutionize partnering. Continue Reading

As biopharma partnering comes of age, it's happening here, there, and everywhere in an expanding universe of new combinations, new business models, new possibilities, new players. That includes the specialty pharma area, domain of one of this year's ASAP BioPharma Conference keynote presenters. Continue Reading

Alliance-manager-turned-CEO Prakash Raman will divulge the skills that will serve alliance professionals with ambitions of penetrating the C-suite, as well as how alliance managers can best serve senior management, in his fireside chat with Christine Carberry at the ASAP BioPharma Conference. Continue Reading

The 2022 ASAP BioPharma Conference will be here before you know it. While you're there, wouldn't you like to take the stage and share your alliance stories and successes with your peers? The spotlight is waiting...and the call for topics runs through May 20. Continue Reading

Looking ahead at your career path? It might help to look back, forward, and all around you. Some of our experienced biopharma veterans weighed in on what makes a good career planning process, the importance of getting the right people on your "team," and knowing your "what" and your "why." Continue Reading

Dicerna Pharmaceuticals put together a rigorous survey of its own employees and those of its partners to solicit undisguised, straightforward commentary on its people and practices—the good, the bad, and the ugly. The exercise was a "heavy lift," said one 2021 ASAP BioPharma Conference presenter. Continue Reading

What happens when your company is acquired by a larger company? And what if it's your partner that gets acquired? The show must go on, and the alliance must continue, but it takes a "maestro" of the art and science of alliance management to navigate through an acquisition and integration. Continue Reading

A recent ASAP BioPharma Conference roundtable found that partners are splitting up sales duty by country, the biopharma partnering ecosystem is getting larger and more complex, internal company transformations are impacting alliances, and not enough attention is being paid to exit strategies. Continue Reading

Few people outside of the technology industry have thought to apply the agile framework to their business. Two Cancer Research UK executives told the story of how the organization used it to revamp how it monitored the overall performance of its clinical trial operation. Continue Reading

Alliances are essential to the success of GE Healthcare's Edison Artificial Intelligence (AI) platform, but it couldn’t simply employ “business as usual” partnering practices. Instead, and ecosystem of partners are creating their own "sandboxes.” Continue Reading